Tumour markers and their prognostic value in adenocarcinoma of the cervix

Tumor Biology

Volumn 19, Issue 6, 1998, Pages 439-444

  Ngan, Hextan Y S ^a   Cheung, Annie N Y ^a   Lander, I J ^a   Cheng, Danny K L ^a   Wong, L C ^a   Ma, H K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenocarcinoma of cervix; CA 125; Carcinoembryonic antigen; Squamous cell carcinoma antigen; Tissue polypeptide antigen

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GYNECOLOGIC CANCER; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; UTERINE CERVIX CARCINOMA;

EID: 0031792879     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030035     Document Type: Article

References (10)

1. Duk JM, Aalders JG, Reuren GJ, Krans M, de Bruijn HWA: Tumour markers CA125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;73:661-668.
2. Rose PG, Baker S, Foumier L, Nelson BE, Hunter RE: Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence. Am J Obstet Gynecol 1993;168:942-946.
3. Meier W, Eiermann W, Stieber P, Schneider A, Fateh Moghadam A, Hepp H: Experiences with SCC antigen, a new tumor marker for cervical carcinoma. Eur J Cancer Clin Oncol 1989;25:1555-1559.
4. Avall-Lundqvist EH, Sjovall K, Nilsson BR, Eneroth PH: Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer 1992;28A: 1695-1702.
5. Lehtovirta P, Viinikka L, Ylikorkala O: Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix. Gynecol Oncol 1990;37:276-278.
6. Leminen A: Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma. Gynecol Oncol 1990;39:358-363.
7. Tomas C, Risteli J, Risteli L, Vuori J, Kauppila A: Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma. Obstet Gynecol 1991;77:566-572.
8. Ferenczy A, Winkler B: Carcinoma and metastatic tumour of the cervix; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. New York, Springer, 1987, pp 218-256.
9. Lo SST, Cheng DKL, Ng TY, Wong LC, Ngan HYS: Prognostic significance of tumour markers in endometnal cancer. Tumor Biol 1997;18:241-249.
10. Duk JM, de Bruijn HW, Groeniger KH, Fleuren GJ, Aakters JG: Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics. Cancer 1990;65:1830-1837.